Agenda

View current Presentations & Handouts  (password required)

25% (minimum) of each presentation will involve interactive learning. All presentations will be followed by a Q & A period.

0730 Breakfast and Registration
Toronto Foyer
0830 Welcome and Opening Remarks
Phillip Segal
Toronto Ballroom
Act 1: Early Diabetes
0840 The Truth about Prediabetes and Vascular Risk
Caroline Kramer
Toronto Ballroom
0905 The Skinny on Pharmacological Weight Loss Therapies
Alice Cheng
Toronto Ballroom
0930 Nutrition Quick Hits: How to provide cultural specific dietary advice
Karen Blekaitis
Toronto Ballroom
0955 Panel Discussion
Toronto Ballroom
1015 Refreshment Break
Toronto Foyer
Act 2: Progression of Diabetes
1035 Top 5 Diabetes Papers of 2019 for the Cardiologist
Jeremy Gilbert
Toronto Ballroom
1100 Cardiovascular Risk Reduction: What can be achieved by lowering blood sugar
Avital Nahmias
Toronto Ballroom
1125 Panel Discussion
Toronto Ballroom
1150 BBDC Diabetes Educator of the Year Award Presentation
Toronto Ballroom
1200 Lunch (provided) and Exhibits
Toronto Foyer
Act 3: Complications of Diabetes
1300 Diabetes Rehab: What are the benefits / Exercise as a tool for managing CV complications of DM
Paul Oh
Toronto Ballroom
1325 Revascularization Treatment in Those with Diabetes
Michael Farkouh
Toronto Ballroom
1350 Antiplatelet Agents Through the Ages: Does it apply to those with diabetes?
Peter Lin
Toronto Ballroom
1415 New Treatments for Diabetic Nephropathy
James Scholey
Toronto Ballroom
1440 Panel Discussion
Toronto Ballroom
1510 Day 1 Summary
Peter Lin
Toronto Ballroom
1525 Refreshment Break
Toronto Foyer
Interactive Breakout Cases 1 (choose one)
1540 Non-Insulin Based Therapies: What comes next after Metformin
Phillip Segal
Toronto Ballroom
1540 Psychosocial Challenges in Diabetes Care
Miranda Boggild
Tom Thomson
1540 Quality Improvement in Diabetes
Julie Gilmour, Geetha Mukerji
Carmichael
1540 When (and when not) to Consider Newer Insulins
Elaine Wylie
Jackson
Interactive Breakout Cases 2 (choose one)
1610 Non-Insulin Based Therapies: What comes next after Metformin
Phillip Segal
Toronto Ballroom
1610 Psychosocial Challenges in Diabetes Care
Miranda Boggild
Tom Thomson
1610 Quality Improvement in Diabetes
Julie Gilmour, Geetha Mukerji
Carmichael
1610 When (and when not) to Consider Newer Insulins
Elaine Wylie
Jackson
1640 Adjourn for the Day

 

0730 Breakfast and Registration
Toronto Foyer
0830 Welcome and Opening Remarks
Barry Rubin
Toronto Ballroom
Act 4: Coronary Disease and Vascular Complications
0840 Risk Stratification of Chest Pain: CT angiography or stress testing
Mini Pakkal
Toronto Ballroom
0905 Antithrombotics in Peripheral Arterial Disease
Eric Kaplovitch
Toronto Ballroom
0930 Management of Peripheral Vascular Disease in Diabetes
Thomas Forbes
Toronto Ballroom
0955 Panel Discussion
Toronto Ballroom
1015 Refreshment Break
Toronto Foyer
Act 5: Valvular Heart Disease and Arrhythmia
1035 TAVR in 2020 – Patient Selection and Outcomes
Eric Horlick
Toronto Ballroom
1100 Bradycardia – High Risk Presentations and Pacemaker Indications
Rebecca Noad
Toronto Ballroom
1125 Contemporary Management of Atrial Fibrillation – From Anticoagulation to Ablation
Andrew Ha
Toronto Ballroom
1150 Panel Discussion
Toronto Ballroom
1210 Lunch (provided) and Exhibits
Toronto Foyer
Act 6: Heart Failure & Cardiac Devices
1310 Medical Therapy for Heart Failure – What do the Guidelines Say?
Michael McDonald
Toronto Ballroom
1335 The Lethal Combination of Heart Failure and Diabetes
Subodh Verma
Toronto Ballroom
1400 Which Device Implant Will Benefit My Patient with Systolic Heart Failure?
Sean Balmain
Toronto Ballroom
1425 Panel Discussion
Toronto Ballroom
1445 Day 2 Summary
Peter Lin
Toronto Ballroom
1500 Refreshment Break
Toronto Foyer
Interactive Breakout Cases 3 (choose one)
1515 Combining Anticoagulant and Antiplatelet Therapy – What is the Safest Approach?
Eric Kaplovitch
Toronto Ballroom
1515 Pragmatic Strategies for the use of SGLT2 Inhibitors in Patients with Diabetes and Cardiovascular Disease
Avital Nahmias
Tom Thomson
1515 HF-PEF Management, Case-Based Discussion
Adriana Luk
Carmichael
1515 Remote Monitoring and Wearable Devices in Heart Failure Care
Juan Duero Posada
Jackson
Interactive Breakout Cases 4 (choose one)
1545 Combining Anticoagulant and Antiplatelet Therapy – What is the Safest Approach?
Eric Kaplovitch
Toronto Ballroom
1545 Pragmatic Strategies for the use of SGLT2 Inhibitors in Patients with Diabetes and Cardiovascular Disease
Avital Nahmias
Tom Thomson
1545 HF-PEF Management, Case-Based Discussion
Adriana Luk
Carmichael
1545 Remote Monitoring and Wearable Devices in Heart Failure Care
Juan Duero Posada
Jackson
1615 Symposium Adjourns